Bristol Myers Squibb Archives - Inside Precision Medicine

Inside Precision Medicine Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders

Translucent robotic looking hand holding a test tube next to a screen showing code and a digital pill to symbolize the use of AI to develop new protein phase separation drugs

News & Features

Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders

February 27, 2024

Related Content

Lipoprotein(a) Lowering Draw Between Lilly and Silence

Lipoprotein(a) Lowering Draw Between Lilly and Silence

In “Quantum Leap,” Almost Half of Adults and Children with NF1 Respond to MEK Inhibitor

In “Quantum Leap,” Almost Half of Adults and Children with NF1 Respond to MEK Inhibitor

Protein Degradation Method Paves a Way for New Cancer Therapies

Protein Degradation Method Paves a Way for New Cancer Therapies

In Conversation with Frank Gleeson

In Conversation with Frank Gleeson